Olanzapin Actavis (Olanzapine)

Olanzapine, the active ingredient in Olanzapin Actavis, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapin Actavis is an atypical antipsychotic that modulates neurotransmitter activity in several psychiatric conditions.

- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): assists  with mood stabilization  and reduction  of manic symptoms. - Bipolar II disorder (depressive episodes): used as adjunct  to alleviate depressive symptoms when other treatments are insufficient. - Schizoaffective disorder  : aids  in controlling both psychotic and mood components. - Psychotic depression  :  provides  adjunctive relief  of depressive and psychotic features.

Olanzapin Actavis may generate a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Dizziness - Increased appetite

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Severe hyperglycaemia or new‑onset diabetes mellitus - Tardive dyskinesia - Agranulocytosis    - Elevated  blood  pressure  or  cardiovascular  events   - Persistent  electro‑  motor  disturb  

Olapan                                                                   """

-   t   t  "     "  "  "  " ullet  \